BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22492685)

  • 1. An evolutionary view of the mechanism for immune and genome diversity.
    Kato L; Stanlie A; Begum NA; Kobayashi M; Aida M; Honjo T
    J Immunol; 2012 Apr; 188(8):3559-66. PubMed ID: 22492685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary comparison of the mechanism of DNA cleavage with respect to immune diversity and genomic instability.
    Begum NA; Honjo T
    Biochemistry; 2012 Jul; 51(26):5243-56. PubMed ID: 22712724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells.
    Sakaguchi N; Maeda K; Kuwahara K
    Scand J Immunol; 2011 Jun; 73(6):520-6. PubMed ID: 21388430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AID targeting in antibody diversity.
    Pavri R; Nussenzweig MC
    Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AID dilemma: infection, or cancer?
    Honjo T; Kobayashi M; Begum N; Kotani A; Sabouri S; Nagaoka H
    Adv Cancer Res; 2012; 113():1-44. PubMed ID: 22429851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes.
    Bahjat M; Guikema JEJ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contested role of uracil DNA glycosylase in immunoglobulin gene diversification.
    Longerich S; Storb U
    Trends Genet; 2005 May; 21(5):253-6. PubMed ID: 15851057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of AID-mediated sequence diversification by cis-acting determinants.
    Yang SY; Schatz DG
    Adv Immunol; 2007; 94():109-25. PubMed ID: 17560273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.
    Imai K; Slupphaug G; Lee WI; Revy P; Nonoyama S; Catalan N; Yel L; Forveille M; Kavli B; Krokan HE; Ochs HD; Fischer A; Durandy A
    Nat Immunol; 2003 Oct; 4(10):1023-8. PubMed ID: 12958596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis- and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification.
    Yeap LS; Meng FL
    Adv Immunol; 2019; 141():51-103. PubMed ID: 30904133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AID mutant analyses indicate requirement for class-switch-specific cofactors.
    Ta VT; Nagaoka H; Catalan N; Durandy A; Fischer A; Imai K; Nonoyama S; Tashiro J; Ikegawa M; Ito S; Kinoshita K; Muramatsu M; Honjo T
    Nat Immunol; 2003 Sep; 4(9):843-8. PubMed ID: 12910268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity.
    Nagaoka H; Tran TH; Kobayashi M; Aida M; Honjo T
    Int Immunol; 2010 Apr; 22(4):227-35. PubMed ID: 20207715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair.
    Matthews AJ; Zheng S; DiMenna LJ; Chaudhuri J
    Adv Immunol; 2014; 122():1-57. PubMed ID: 24507154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.